Gender differences in molecular remodeling in pressure overload hypertrophy  by Weinberg, Ellen O et al.
Gender Differences in Molecular
Remodeling in Pressure Overload Hypertrophy
Ellen O. Weinberg, PHD, Christiane D. Thienelt, MD, Sarah E. Katz, BA, Jozef Bartunek, MD,
Minori Tajima, MD, PHD, Susanne Rohrbach, Pamela S. Douglas, MD, FACC,
Beverly H. Lorell, MD, FACC
Boston, Massachusetts
OBJECTIVES The objective of this study was to examine gender differences in left ventricular (LV) function
and expression of cardiac genes in response to LV pressure overload due to ascending aortic
stenosis in rats.
BACKGROUND Clinical studies have documented gender differences in the pattern of adaptive LV hypertro-
phy. Whether these differences result from intrinsic differences in molecular adaptation to
pressure overload between men and women, or are related to other factors is not known.
METHODS Male (n 5 8) and female (n 5 8) Wistar rats underwent ascending aortic stenosis and were
studied 6 weeks after banding with gender-matched control rats (male n 5 7; female n 5 7).
The LV contractile reserve was examined in isolated hearts from each group. We compared
LV messenger ribonucleic acid (mRNA) levels of atrial natriuretic factor (ANF), beta-myosin
heavy chain, sarcoplasmic reticulum Ca21–adenosine triphosphatase (ATPase) and Na1–
Ca21 exchanger. Reverse transcriptase polymerase chain reaction was used to identify
estrogen receptor transcript in cardiac myocytes and LV tissue.
RESULTS The magnitude of LV hypertrophy (LVH) and systolic wall stress were similar in male and
female animals with LVH. Male LVH hearts demonstrated a depressed contractile reserve;
in contrast, contractile reserve was preserved in female LVH hearts. The expression of
beta-myosin heavy chain and ANF mRNA was greater in male versus female LVH hearts.
Sarcoplasmic reticulum Ca21-ATPase mRNA levels were depressed in male LVH but not in
female LVH compared with control rats, and Na1–Ca21 exchanger mRNA levels were
increased similarly in both male and female LVH hearts. Estrogen receptor transcript was
detected in both adult male and female cardiac myocytes and LV tissue.
CONCLUSIONS There are significant gender differences in the LV adaptation to pressure overload despite a
similar degree of LVH and systolic wall stress in male and female rats. There is the potential
for estrogen signaling through the adult myocyte estrogen receptor in both male and female
rats to contribute to gender differences in gene expression in pathologic hypertrophy. (J Am
Coll Cardiol 1999;34:264–73) © 1999 by the American College of Cardiology
Clinical studies have recently documented gender differ-
ences in the pattern of adaptive left ventricular (LV)
hypertrophy (LVH) in response to increased afterload, such
as occurs in aortic stenosis and hypertension. Cardiac
performance is more frequently preserved in female com-
pared with male patients with a similar degree of aortic
stenosis and female patients more frequently demonstrate
preserved or supernormal ejection parameters with small
thick-walled chambers (1–5). The risk of adverse outcome
in hypertensive patients associated with LVH is also influ-
enced by gender (6,7). Whether these differences result
from intrinsic differences in molecular adaptation to pres-
sure overload between men and women, or are related to
differences in age, degree of stenosis, underlying coronary
artery disease, LV geometry per se or other factors extrinsic
to the myocardium is not known.
We have extensively characterized the ascending aortic
stenosis model of pressure overload LVH in male rats
(8–15). Early after aortic banding in male rats, compensa-
tory concentric hypertrophy is evident in conjunction with
reexpression of LV hypertrophic genes, including beta-
myosin heavy chain, alpha-skeletal-actin and atrial natri-
uretic factor (ANF). Later, a transition to failure becomes
evident by depressed in vivo LV contractile indexes and
progressive reduction in message levels of sarcoplasmic
reticulum Ca21–adenosine triphosphatase (SERCA-2)
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with persistent up-regulation of the hypertrophic gene
program.
The objective of the present study was to determine
whether there are differences between male and female rats
in LV Ca21-dependent contractile reserve and gene expres-
sion in response to chronic pressure overload in the absence
of differences in age, duration and degree of aortic stenosis.
METHODS
Preparation of animals. Under anesthesia with intraperi-
toneal methohexital sodium (50 mg/kg), ascending aortic
stenosis was created in male (n 5 8) and female (n 5 8)
Wistar rats (70 to 90 g) obtained from Charles River
Breeding Laboratories (Wilmington, Massachusetts), by
placing a 0.56-mm internal diameter tantalum clip on the
ascending aorta via a thoracic incision (LVH groups) as
previously described (8–15). Body weights and age at the
time of banding were similar in both groups. Additional
male (n 5 7) and female (n 5 7) age-matched animals
underwent sham operation to serve as controls (control
groups). Animals were housed in a viral-antigen–free facility
and were fed normal rat chow and water ad libitum.
Animals were studied six weeks after aortic banding. The
model is characterized by concentric LVH, the absence of
chamber dilation and preserved ejection indexes at this stage
after aortic stenosis in both male and female animals with
LVH (11).
In vivo measurements. Six weeks after banding, rats from
each group underwent transthoracic echocardiographic and
hemodynamic assessment for estimation of LV systolic
meridional wall stress as previously described by our labo-
ratory (8,9,11). Just before sacrifice, rats were anesthetized
with intraperitoneal sodium pentobarbital (50 mg/kg) and
in vivo LV systolic and diastolic pressures were obtained by
closed chest LV catheterization as previously described by
our laboratory (8–13,16). Left ventricular meridional sys-
tolic wall stress (kdyn/cm2) was estimated as: 0.334 3 in
vivo LV systolic pressure 3 (LVD/[1 1 PWT/LVD])
where LVD 5 LV internal dimension and PWT 5
posterior wall thickness at end-systole. Left ventricular
diastolic stress (kdyn/cm2) was estimated as 0.334 3 in vivo
LV diastolic pressure 3 (LVD/[1 1 PWT/LVD]) where
LVD 5 LV internal dimension and PWT 5 posterior wall
thickness measured in centimeters at end-diastole. At the
time of sacrifice, body weights were recorded and tibial
lengths were obtained as indexes of growth.
Assessment of contractile reserve. The isolated hearts
were subjected to hemodynamic evaluation using the iso-
volumic buffer-perfused rat heart preparation as described in
detail from our laboratory (8,10). In brief, hearts were
rapidly removed and perfused with modified Krebs Hense-
leit buffer through a short cannula inserted into the aortic
root just below the level of the clip. Coronary flow rate was
adjusted to achieve a mean coronary perfusion pressure of
110 mm Hg in hearts from aortic stenosis rats and
75 mm Hg in hearts from control rats, and was then held
constant, achieving comparable myocardial perfusion rates
per gram of LV tissue in all groups (8,10). A collapsed latex
balloon, slightly larger than the LV chamber, was placed in
the LV and continuous LV pressure was measured via a
Statham pressure transducer (Gould Instruments, Valley
View, Ohio) connected to the balloon. Heart rate was held
constant at 240 beats/min through external pacing (Grass
Instruments, Quincy, Massachusetts). Temperature was
maintained at 37°C.
At the end of a 20-min stabilization period, Ca21-
dependent contractile reserve was assessed as described by
our laboratory (8,10,14,16). Left ventricular systolic pres-
sure generation was measured at three perfusate calcium
concentrations (0.6, 1.5 and 3.0 mmol/liter) at constant
similar LV balloon volume. After hemodynamic evaluation,
hearts were rapidly dissected into left and right ventricles,
weighed, frozen in liquid nitrogen and stored at 280°C.
Analysis of LV messenger ribonucleic acid (mRNA)
levels. Total RNA was extracted from frozen LV tissue
using TriReagent (Sigma, St. Louis, Missouri). For North-
ern blot analyses, 20 mg total RNA from individual LV
samples was size-fractionated by electrophoresis in a 1.5%
agarose-formaldehyde gel and transferred to a nitrocellulose
membrane (Stratagene, La Jolla, California) by pressure
transfer (Posiblot Pressure Blotter, Stratagene). The mem-
brane was prehybridized for 10 min and hybridized with
specific probes for 1 h in QuikHyb solution (Stratagene) at
65°C. After hybridization, the membrane was washed and
exposed to Kodak (Rochester, New York) MR film for 0.25
to 3 days. The relative amounts of each mRNA were
determined by densitometric analysis (Molecular Dynamics,
Sunnyvale, California) and normalized to glyceraldehyde
phosphate dehydrogenase. Stripping the membrane for
reuse was performed following the manufacturer’s instruc-
tions (Stratagene). Probes used were the complementary
deoxyribonucleic acid (cDNA) fragment encoding the
SERCA-2 (provided by D. MacLennan), the cDNA frag-
ment encoding the rat Na1–Ca21 exchanger (provided by I.
Komuro), the cDNA fragment encoding rat glyceraldehyde
phosphate dehydrogenase, an 84-bp synthetic oligonucleo-
tide complementary to the coding region of rat ANF and a
Abbreviations and Acronyms
ANF 5 atrial natriuretic factor
cDNA 5 complementary deoxyribonucleic acid
LV 5 left ventricular
LVH 5 left ventricular hypertrophy
mRNA 5 messenger ribonucleic acid
PCR 5 polymerase chain reaction
RT 5 reverse transcriptase
SERCA-2 5 sarcoplasmic reticulum Ca21–adenosine
triphosphatase
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20-bp synthetic oligonucleotide complementary to the rat
beta-myosin heavy chain gene. The cDNA fragments were
radiolabeled with (gamma-32P) deoxycytidine triphosphate
(New England Nuclear, Boston, Massachusetts) using ran-
dom priming (Boehringer Mannheim, Indianapolis, Indi-
ana), and the oligonucleotides were radiolabeled with
(alpha-32P) adenosine triphosphate using T4 polynucleotide
kinase.
Dissociation of LV myocytes. Left ventricular myocyte
isolation was performed as previously described (14–16).
Rats were anesthetized with intraperitoneal pentobarbital
(65 mg/kg body weight), and the heart was rapidly excised
and attached to an aortic cannula. The heart was initially
perfused with nominally Ca21-free modified Krebs Hense-
leit buffer for 3 min. The heart was then perfused with
recirculating buffer supplemented with 0.6 mg/ml collage-
nase (Class II, Worthington Biochemical Corp, Lake
Wood, New Jersey), 0.04 mg/ml protease (Type XIV;
Sigma) for 20 to 30 min. The heart was then removed from
the cannula, the right ventricle was removed and the left
ventricle was cut into small pieces, and dispersion of
myocytes was performed by gentle agitation of tissue
through a serologic pipette. The suspension was forced
through a 450-mm nylon screen filtration cloth. The myo-
cytes were then resuspended in HEPES buffer, pH 7.4,
rinsed twice and allowed to settle before RNA extraction.
The cell dissociation procedure routinely yields 97% to 99%
myocytes and less than 1% endothelial cells or unstained
cells (fibroblasts), respectively.
Polymerase chain reaction (PCR) cloning and sequenc-
ing of estrogen receptor cDNA from adult cardiac myo-
cytes. First-strand cDNA was synthesized from 5 mg total
RNA from female and male LV cardiac myocytes, and LV
tissue from male and female LVH rats using estrogen receptor
gene specific primers (17) and the SUPERSCRIPT Pream-
plification System (Gibco Life Technologies, Gaithersburg,
Maryland). Samples without reverse transcriptase (RT)
served as negative controls to rule out amplification of
genomic DNA. The cDNAs were used for PCR (Perkin
Elmer Model 9600, Branchburg, New Jersey) using taq
DNA polymerase (Gibco BRL). The temperature program
for the amplifications was 30 cycles of 1 min at 94°C, 1 min
at 57°C and 2 min at 72°C. Polymerase chain reaction
products were resolved on a 1% agarose gel and the
anticipated major PCR product of 741 base pairs was
excised, purified (GeneClean II, Bio 101) and cloned into
TA Cloning Vector (Invitrogen, Carlsbad, California). The
resulting plasmids were transformed into DH5-alpha Esch-
erichia coli (Gibco BRL), and recombinant DNA was
purified and subjected to bidirectional automated sequenc-
ing (Applied Biosystems, Branchburg, New Jersey) at the
Molecular Core Facility at Beth Israel Deaconess Medical
Center.
Statistical analysis. All values are expressed as mean 6
SEM. Data in Table 1 were analyzed by two-factor analysis
of variance. Otherwise, statistical significance was tested
between groups using Student t test (Fig. 1) or analysis of
variance for repeated measures (Fig. 2) and Fisher protected
least significant difference method for post hoc analyses.
Significance was accepted at the level of p , 0.05. Corre-
lation coefficients were obtained using linear regression (the
method of least squares).
RESULTS
Magnitude of LV hypertrophy and in vivo function.
Characterization of animals and measurements of in vivo
LV function for all groups are shown in Table 1. Body
weights were significantly lower in female rats compared
with male rats. Body weight was slightly lower in the male
group with LVH compared with the male control group and
slightly higher in the female group with LVH compared
with the female control group. Tibial length, an index of
growth independent of body fat, muscle mass or fluid
homeostasis, was significantly greater in male compared
with female rats, but there were no significant effects of
LVH on tibial length. Left ventricular weight was signifi-
Table 1. Characterization of Hypertrophy and In Vivo Left Ventricular Function
Group BW (g) TL (mm) LVW (g)
LVW/BW
(g/kg)
LVW/TL
(g/cm)
LV EDP
(mm Hg)
LVSP
(mm Hg)
LV Stress
(kdyn/cm2)
Male control 378 6 5 37.9 6 0.3 0.92 6 0.02 2.44 6 0.07 24.4 6 0.4 5 6 1 98 6 8 23.1 6 3.8
Male LVH 351 6 6 38.3 6 0.3 1.56 6 0.034 4.45 6 0.14 40.8 6 1.0 20 6 3 149 6 15 41.3 6 7.7
Female control 231 6 4 35.3 6 0.3 0.66 6 0.030 2.87 6 0.13 18.8 6 0.9 4 6 1 90 6 6 31.9 6 9.2
Female LVH 251 6 8 35.7 6 0.2 1.11 6 0.090 4.47 6 0.36 31.3 6 2.5 12 6 3 166 6 12 49.7 6 9.9
Two-factor ANOVA
Gender 0.0001 0.0001 0.0001 NS 0.0001 NS NS NS
LVH NS NS 0.0001 0.0001 0.0001 0.0002 0.0001 0.002
Interaction 0.001 NS NS NS NS NS NS NS
Data were analyzed using two-factor analysis of variance (ANOVA). The significance (p value) of gender, left ventricular hypertrophy (LVH), and the interaction of gender and
LVH is shown in italics. NS, p . 0.05. Values are mean 6 SE.
BW 5 body weight; LV EDP 5 left ventricular end-diastolic pressure; LVSP 5 LV systolic pressure; LV Stress 5 LV systolic meridional wall stress; LVW 5 LV weight;
TL 5 tibial length.
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cantly less in female hearts compared with male hearts and
LV weight was significantly increased in both LVH groups.
The magnitude of the increase in LVH weight was similar
in male (69%) and female (68%) groups with LVH com-
pared with their control groups (interaction p 5 NS). The
LV weight/body weight was significantly increased in both
male and female groups with LVH, and the magnitude of
the increase was similar between both groups with LVH
compared with their control groups (interaction p 5 NS).
The LV weight/tibial length was increased in both male and
female rats with LVH compared with gender-matched
control rats, and the magnitude of the increase was similar
between both groups with LVH (interaction, p 5 NS).
There were no significant effects of gender alone on LV
end-diastolic pressure, LV systolic pressure and LV systolic
stress. However, there was a significant effect of LVH on all
three parameters, but there was no interaction between
gender and LVH (p 5 NS). Figure 1 illustrates the
magnitude of LVH (LV weight/tibial length) in absolute
values (left) and as a percent of gender control (middle), and
LV systolic wall stress in male and female LVH hearts
(right). The percent increase in LV weight/tibial length,
and LV systolic wall stress were both similar in male and
female LVH groups. Left ventricular diastolic wall stress
was increased in both male and female groups with LVH
compared with gender-matched control rats (4.50 6 0.84
vs. 1.30 6 0.14, and 2.12 6 0.53 vs. 0.68 6 0.12 kdyn/cm2,
respectively, both p , 0.05) and was higher in male versus
female LVH (p , 0.05).
Isolated heart studies: LV contractile reserve. In the
isolated perfused hearts, coronary flow rate per gram was
similar among all groups (male control rats, 16.9 6 0.7;
male LVH 15.60 6 0.7; female control rats, 16.0 6 0.9;
female LVH 16.7 6 1.6 ml/min per g, p 5 NS). Left
ventricular contractile reserve was examined by the dose–
response relationship between LV systolic developed pres-
sure per gram LV and perfusate calcium concentration
(three calcium concentrations examined in each heart: 0.6,
1.5 and 3.0 mmol/liter) at identical LV balloon volumes. As
shown in Figure 2, the LV calcium-dependent contractile
reserve was similar in female LVH and control hearts. In
contrast, male LVH hearts demonstrated a significantly
depressed contractile reserve compared with control hearts
(p # 0.001). Since myocardial perfusion rates were similar
in all groups, the depressed contractile reserve observed in
male LVH hearts cannot be accounted for by differing levels
of myocardial perfusion. Rates of contraction, assessed by
first derivative of LV pressure/LV pressure, were not de-
pressed in either male or female LVH groups, compared
with their gender-matched controls (male: 66.2 6 0.7 vs.
61.3 6 1.0; female 65.1 6 2 vs. 72.2 6 4.5 s21, respectively,
both p 5 NS). Rates of relaxation, assessed by negative first
derivative of LV pressure/LV pressure, were not depressed
in either male or female LVH groups, compared with their
gender-matched controls (male: 48 6 2.1 vs. 45.4 6 1.6;
Figure 1. Left ventricular (LV) weight to tibial length ratio (left, LV/TL); LV weight to tibial length ratio as a percent of gender-matched
control rats (middle, LV/TL, % Control), and LV meridional systolic wall stress (right, LV Systolic Stress). Values are mean 6 SEM.
LVH 5 LV hypertrophy.
Figure 2. Relation between left ventricular (LV) developed pres-
sure per gram LV (LV DevP/g) versus perfusate calcium concen-
tration. Values are mean 6 SE. Open squares 5 male control;
solid squares 5 male LV hypertrophy; open circles 5 female
control; solid circles 5 female LV hypertrophy. *p 5 0.001 versus
all groups.
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female: 36.6 6 1.8 vs. 42.0 6 1.9 s21, respectively, both p 5
NS).
Left ventricular gene expression. We examined LV steady
state mRNA levels for fetal genes induced by pressure
overload (ANF, beta-myosin heavy chain), and that modify
calcium homeostasis (SERCA-2, Na1–Ca21 exchanger). In
normal male and female rats, there were no differences in
LV message levels of beta-myosin heavy chain, ANF,
SERCA-2 or Na1–Ca21 exchanger (Table 2). The message
levels in the LVH groups were both analyzed as absolute
densitometric values, and expressed relative to values seen in
same-gender control rats. The message levels of both
beta-myosin heavy chain and ANF were increased in male
and female LVH groups compared with their gender-
matched controls, both p , 0.05; however, the expression of
both genes was higher in male compared with female LVH
rats (p , 0.01), as illustrated in Figure 3. A significant
inverse correlation between LV developed pressure/g versus
beta-myosin heavy chain mRNA levels was observed in
hearts with LVH (r 5 0.73, p 5 0.001). As illustrated in
Figure 4, the steady state SERCA-2 mRNA levels in male
LVH hearts were 58% of levels in male control hearts,
whereas there was only a slight and nonsignificant depres-
sion of SERCA-2 mRNA levels in female LVH hearts
compared with female control hearts. Message levels of
SERCA-2 normalized to the values of gender-matched
control hearts were also significantly lower in male LVH
hearts compared with female LVH hearts (p , 0.01). As
shown in Figure 5, Na1–Ca21 exchanger mRNA levels
were significantly increased approximately twofold in both
male and female LVH hearts compared with their gender-
matched control groups.
Estrogen receptor transcript in adult LV myocytes and
LV tissue. Our findings of gender differences in gene
expression in response to pressure overload raise the possi-
bility that estrogen signaling through the myocyte estrogen
receptor may contribute to these differences. To date, there
are no reports of the expression of the estrogen receptor in
adult cardiac myocytes, although the presence of estrogen
receptor protein in neonatal cardiac myocytes and fibro-
blasts was recently reported (18). To determine if estrogen
receptor transcript could be detected in adult LV myocytes
and LV tissue, nonquantitative RT-PCR was performed on
Figure 3. Beta-myosin heavy chain (top left, b-MHC) and atrial natriuretic factor (top right, ANF) messenger ribonucleic acid (mRNA)
levels normalized to glyceraldehyde phosphate dehydrogenase (GAPDH) in densitometry units, and expressed as relative increase to
gender-matched control (Con) hearts. Values are mean 6 SE. Bottom shows representative samples from Northern blotting showing
mRNA expression of beta-myosin heavy chain, ANF and GAPDH. LVH 5 left ventricular hypertrophy.
Table 2. Left Ventricular Gene Expression in Male and Female
Normal Rats
Male Female p
ANF 5.97 6 1.41 4.96 6 0.84 NS
Beta-myosin heavy chain 1.94 6 0.59 3.39 6 0.82 NS
Sarcoplasmic reticulum
Ca21–adenosine
triphosphatase
0.50 6 0.05 0.41 6 0.05 NS
Na1–Ca21 exchanger 0.90 6 0.19 0.80 6 0.16 NS
Data are given in densitometry units, indicating relative amounts of each messenger
ribonucleic acid determined by densitometric analysis and normalized by glyceralde-
hyde phosphate dehydrogenase. Values are mean 6 SE.
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RNA isolated from female and male myocytes, and from
LV tissue from female and male LVH hearts. We amplified
a 741-bp cDNA fragment within two highly conserved
regions of the rat uterine estrogen receptor: the DNA
binding domain and the estrogen binding domain. This is
shown in Figure 6. The 741-bp product was found in all
Figure 4. Sarcoplasmic reticulum Ca21–adenosine triphosphatase (SERCA-2) mRNA levels normalized to GAPDH in densitometry
units, and expressed as relative increase to gender-matched control hearts. Values are mean 6 SE. Bottom shows representative samples
from Northern blotting showing RNA expression of SERCA-2 and GAPDH. Abbreviations as in Figure 3.
Figure 5. Na1–Ca21 exchanger RNA levels normalized to GAPDH in densitometry units (left) and expressed as relative increase to
gender-matched controls (right). Values are mean 6 SE. Bottom shows representative samples from Northern blotting showing RNA
expression of Na1–Ca21 exchanger and GAPDH. Abbreviations as in Figure 3.
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samples examined and is 91% homologous to the rat uterine
estrogen receptor (GenBank accession number Y00102).
Also shown in Figure 6, additional smaller bands were
obtained in all samples, which may represent exon skipping
isoforms that have been previously described (17,19). No
PCR products were obtained in samples without RT (lanes
2, 4, 6, 8).
DISCUSSION
Gender and LV hypertrophy. Gender-related differences
in the response to pressure overload have been shown in
humans with aortic stenosis and hypertension (1–7). Men
with aortic stenosis exhibit ventricular dilation and earlier
ventricular dysfunction, which has been attributed in part to
more favorable geometric remodeling in women (2). In this
rat model of ascending aortic stenosis, we have also observed
an earlier transition to failure manifest as LV dilation and
depressed systolic performance in male compared with
female subjects (11). Comparison of gender effects on LVH
in humans with aortic stenosis or hypertension and young
rats with ascending aortic constriction must be done with
caution because clinical studies have been performed pre-
dominantly in older patients in whom confounding effects
of senescence may modify cardiac growth (20).
However, recent observations in different species and
models of hypertrophy suggest gender-related differences in
adaptation and secondary failure. Differences in geometric
remodeling and an earlier onset of impaired systolic pump
performance in male versus female animals have also been
reported in the spontaneously hypertensive rat model (21)
and in preliminary studies of hypertrophied transgenic mice
with cardiac specific expression of mutant myosin heavy
chain (22). These studies have not clarified whether gender-
related differences are solely related to differences in geo-
metric remodeling or may in part be related to differences in
cardiac gene expression that precede the development of
heart failure. In the present study, we prove for the first time
that there are striking gender-related differences in the
expression of key genes that are known to play critical roles
in cardiac calcium regulation and contractile function at an
early stage of chronic pressure overload before the develop-
ment of overt failure.
Pressure overload LVH model. The ascending aortic
stenosis rat model is a relatively pure mechanical pressure
overload model in which concentric LVH with minimal
collagen deposition develops in response to a sustained
elevation of LV systolic pressure in the absence of systemic
hypertension, or systemic neurohumoral and renin–
angiotensin system activation (8–12). We chose to examine
possible gender-related differences in cardiac gene expres-
sion at an early stage of compensatory LVH six weeks after
aortic stenosis when cardiac dilation is absent and basal
indexes of in vivo and isolated myocyte contractile function
are preserved, before the later development of overt heart
failure and impaired survival in male aortic stenosis rats
(8–14).
In this study, the age of onset and duration of experi-
mental aortic stenosis were identical in male and female
animals, and potential variables that limit clinical studies
such as duration and magnitude of aortic stenosis, coronary
artery disease and the confounding variable of senescence
were absent. A potential limiting factor in this model is the
comparability of the imposed systolic pressure load, because
a similar size clip was placed on the aortas of the male and
female weanling rats, whereas the males grow to larger
absolute body and heart size. For this reason, we assessed
systolic load by the estimation of meridional systolic wall
stress, which takes into account the magnitude of LV
systolic pressure, cavity size and wall thickness. In corrob-
oration of prior studies of female and male aortic stenosis
rats at this stage of LVH (11), the magnitude of systolic wall
stress was similar in male and female aortic stenosis rats. In
response to this systolic pressure overload, the magnitude of
LVH was similar in male and female aortic stenosis rats.
We have previously shown that calcium-dependent con-
tractile reserve may be abnormal in isolated perfused hearts
and myocytes from male rats with aortic stenosis (8,10) and
rats with postinfarction remodeling (16) compared with
control animals despite similar basal LV systolic contractile
function indexes. We used isolated perfused hearts and
observed that LV systolic pressure generation to the eleva-
tion of perfusate calcium was similar in female LVH and
control hearts; in contrast, calcium-dependent contractile
reserve was depressed in the male LVH hearts.
Gender and cardiac gene expression. Interpretation of
gender-related changes in cardiac gene reprogramming
must take into consideration any basal differences in gene
expression in normal male and female animals of identical
age. There were no differences in densitometric measure-
ments of message levels of ANF and beta-myosin heavy
chain in normal male and female rats, which are present in
very low abundance in the normal adult left ventricle. There
were also no differences in LV SERCA-2 and Na1–Ca21
exchanger mRNA levels in normal male and female rats. A
Figure 6. Identification of estrogen receptor transcript by reverse
transcriptase polymerase chain reaction (RT-PCR). Figure shows
RT-PCR products in adult rat female and male myocytes, and in
left ventricular (LV) tissue from female and male LV hypertrophy
(LVH) hearts. The sequence of the major 741-bp product was
homologous to uterine estrogen receptor. No PCR products were
obtained from negative control samples in the absence of reverse
transcriptase (lanes 2, 4, 6, 8).
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limitation of this analysis is that we measured steady state
mRNA levels and did not analyze protein levels or down-
stream functional events unique to these proteins. However,
multiple prior studies in experimental models have shown a
very close correlation between cardiac mRNA levels of these
specific well-studied genes and their resultant proteins
(23–33).
Pressure overload LVH in multiple animal models and
human heart failure is associated with the up-regulation of
cardiac genes and isoforms that are normally expressed in
fetal life and down-regulated in the postnatal left ventricle
(22–33). We have also detected these changes in cardiac
gene expression in male rats subjected to this aortic stenosis
model (12). In the present study, we made the unexpected
observation that message levels of both beta-myosin heavy
chain and atrial natriuretic factor were higher in male
compared with female aortic stenosis animals, despite a
similar magnitude of LVH as well as systolic load. Although
the increase in message levels of the Na1–Ca21 exchanger
was similar in male and female LVH groups, message levels
of SERCA-2 were markedly depressed in male but not in
female LVH animals at this early stage of hypertrophy.
These observations suggest that the “gain” of mechano-
transduction of systolic load may be higher in male com-
pared with female hearts. Alternatively, there is the formal
possibility that factors such as diastolic wall stress, which
was slightly higher in male versus female aortic stenosis rats,
background gender-specific genetic factors or differences in
hormonal growth peptides may modulate cardiac gene
expression distinct from changes in LV mass.
The depression of contractile reserve that we observed in
male animals with LVH compared with female rats with
LVH may be explained in part by the greater up-regulation
of beta-myosin heavy chain in the male rats with LVH.
This up-regulation of beta-myosin heavy chain isoform is
usually accompanied by variable reductions in the expression
of alpha-myosin heavy chain isoform, which was not mea-
sured in this study. We observed an inverse relationship
between message levels of beta-myosin heavy chain and
systolic developed pressure in the male and female rats with
LVH. It is well established that a reduction in myosin
adenosine triphosphatase activity associated with the switch
from V1 to V3 isoenzyme contributes to a slowed velocity of
muscle shortening and force development in isolated mus-
cle, which may contribute to impaired levels of force
development at high work loads and physiologic heart rates
(34,35). In this study, the depressed expression of
SERCA-2, which was observed in the male but not the
female rats with LVH, may also contribute to the depressed
contractile reserve in the male group. Our observation of a
potential gender-related modulation of SERCA-2 expres-
sion in pressure overload hypertrophy is novel.
The expression of SERCA-2 and its relationship to
excitation–contraction coupling has been the subject of
intense interest in humans and experimental models of
LVH and heart failure (24–26,30–33,36–39). In the end-
stage dilated failing human heart (36–38) as well as exper-
imental models of advanced heart failure (39), message and
protein levels of SERCA-2 are usually markedly depressed
and associated with depressed levels of peak systolic intra-
cellular [Ca21]. Recent studies in end-stage failing human
hearts have also shown variable increases in message and
protein levels of the Na1–Ca21 exchanger, leading to the
speculation that increased activity of the exchanger in the
forward mode to promote calcium efflux may modify cal-
cium loading (40,41). In the normal rat, the contribution of
Na1–Ca21 exchange to intracellular calcium homeostasis
has been shown to be much less than in other species, with
a greater contribution of the sarcoplasmic reticulum aden-
osine triphosphatase pump (33).
Estrogen and cardiac gene expression. In this study, we
positively identified the estrogen receptor transcript in both
adult male and female myocytes and LV tissue. Much
further work will need to be done to determine if there are
quantitative differences in message and receptor levels and
their ligand-binding kinetics between male and female adult
hearts. However, our observations provide proof-of-concept
of the potential for estrogen to modify adult cardiac myocyte
gene expression in both male and female subjects. Serum
levels of estrogen are 8- to 12-fold higher in female
compared with male rats (42,43). Indirect evidence strongly
implicates estrogen regulation of expression of the myosin
heavy chain isoforms and some other major structural
proteins (42,44,45). Gender-related differences in cardiac
gene expression of myosin heavy chain isoforms and struc-
tural matrix proteins were found in normal postpubertal but
not neonatal rats (46), and in the spontaneously hyperten-
sive rat (47). Future experiments are needed to elucidate the
direct effects of estrogen receptor signaling on the transcrip-
tion of beta-myosin heavy chain isoform, SERCA-2 and
other proteins with key regulatory effects on excitation–
contraction coupling.
In summary, chronic pressure overload in rats with
ascending aortic stenosis is associated with gender-related
differences in key cardiac genes implicated in contractile
function and calcium homeostasis. Our findings support the
hypothesis that gender-related differences in cardiac gene
expression occur at an early stage of hypertrophy before the
development of overt failure, and may contribute to the
depression of contractile reserve. Future studies are war-
ranted to determine if estrogen directly affects growth of
adult myocytes and modifies transcription of cardiac genes
involved in hypertrophic growth and contractility.
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